we are

55% of UK cancer deaths are from rare and less common cancers.

Despite this, these cancers remain severely under represented and

under-funded across all areas, including policy, services and research.

Cancer52 is an alliance of over 100 organisations working to address this inequality and improve outcomes for patients with these highly challenging diseases.

47%

of diagnoses are for rare and less common cancers

55%

we are

47%

of diagnoses are for rare and less common cancers

55%

of deaths are

from rare and less common cancers

8%

why are diagnosis and death stats so different?

We work on matters that impact on the

rare and less common cancer community.

These are our objectives:

Partnership: Unify and empower our member organisations.

Patients: Use our unique structure to capture the patient voice of those with rare and less common cancers.

Policy: Take that voice on to those bodies and individuals who influence cancer policy, science, clinical outputs, services and treatment.

@Cancer52org